Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Public ClinicalTrials.gov record NCT03717506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of GDC 268 and Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to evaluate the safety, tolerability, and therapeutic equivalence of GDC 268 to Clindamycin Phosphate Topical Lotion, 1% and to compare the efficacy of these two products to the GDC vehicle lotion (i.e., placebo) in the treatment of acne vulgaris.
Study identification
- NCT ID
- NCT03717506
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,236 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 10, 2018 (Actual)
- Primary completion
- Feb 17, 2020 (Actual)
- Completion
- Apr 16, 2020 (Actual)
- Last update posted
- May 4, 2021
2018 – 2020
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 07 | Fort Smith | Arkansas | 72916 | — |
| Site 22 | Rogers | Arkansas | 72758 | — |
| Site 25 | Fountain Valley | California | 92708 | — |
| Site 33 | Northridge | California | 91324 | — |
| Site 30 | San Diego | California | 92103 | — |
| Site 44 | Aventura | Florida | 33180 | — |
| Site 36 | Brandon | Florida | 33511 | — |
| Site 45 | DeLand | Florida | 32720 | — |
| Site 41 | Largo | Florida | 33770 | — |
| Site 38 | Miami | Florida | 33145 | — |
| Site 35 | Miami Lakes | Florida | 33014 | — |
| Site 37 | North Miami Beach | Florida | 33162 | — |
| Site 26 | St. Petersburg | Florida | 33709 | — |
| Site 42 | Tampa | Florida | 33609 | — |
| Site 01 | West Palm Beach | Florida | 33406 | — |
| Site 10 | Newnan | Georgia | 30263 | — |
| Site 09 | Boise | Idaho | 83704 | — |
| Site 05 | Rolling Meadows | Illinois | 60008 | — |
| Site 02 | Plainfield | Indiana | 46168 | — |
| Site 27 | Overland Park | Kansas | 66215 | — |
| Site 28 | Clarkston | Michigan | 48346 | — |
| Site 24 | Fridley | Minnesota | 55432 | — |
| Site 49 | Omaha | Nebraska | 68134 | — |
| Site 06 | High Point | North Carolina | 27262 | — |
| Site 32 | Raleigh | North Carolina | 27612 | — |
| Site 19 | Dublin | Ohio | 43016 | — |
| Site 17 | Gresham | Oregon | 97030 | — |
| Site 34 | Philadelphia | Pennsylvania | 19103 | — |
| Site 20 | Warwick | Rhode Island | 02886 | — |
| Site 08 | Anderson | South Carolina | 29621 | — |
| Site 29 | Chattanooga | Tennessee | 37421 | — |
| Site 03 | Murfreesboro | Tennessee | 37130 | — |
| Site 04 | Nashville | Tennessee | 37215 | — |
| Site 43 | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03717506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03717506 live on ClinicalTrials.gov.